ITUS Corp Share Price OTC Bulletin Board
Equities
ITUS
US45069V1044
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 91.55M 7.64B |
---|---|---|---|---|---|
Net income 2024 * | -14M -1.17B | Net income 2025 * | -15M -1.25B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.52
x | P/E ratio 2025 * |
-6.38
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.09% |
Latest transcript on ITUS Corp
Managers | Title | Age | Since |
---|---|---|---|
Amit Kumar
CEO | Chief Executive Officer | 59 | 01/12/01 |
Michael Catelani
DFI | Director of Finance/CFO | 57 | 01/16/01 |
Pamela Garzone
PRN | Corporate Officer/Principal | 69 | 07/21/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Titterton
BRD | Director/Board Member | 79 | 01/99/01 |
Amit Kumar
CEO | Chief Executive Officer | 59 | 01/12/01 |
Emily Gottschalk
BRD | Director/Board Member | 63 | 23/19/23 |
1st Jan change | Capi. | |
---|---|---|
+24.45% | 47.02B | |
+49.67% | 41.86B | |
+0.38% | 41.76B | |
-4.27% | 28.8B | |
+12.59% | 26.05B | |
-21.26% | 19.15B | |
+3.98% | 12.55B | |
+31.54% | 12.34B | |
-4.44% | 11.82B |
- Stock Market
- Equities
- ANIX Stock
- ITUS Stock